|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/17/2024 |
$5.50 |
$5.63 |
$5.21 |
$5.27 |
2.15M | 04/18/2024 |
$5.27 |
$5.35 |
$4.98 |
$5.04 |
2.34M | 04/19/2024 |
$4.95 |
$5.11 |
$4.70 |
$4.79 |
2.69M | 04/22/2024 |
$4.84 |
$4.92 |
$4.67 |
$4.78 |
1.43M | 04/23/2024 |
$4.79 |
$5.02 |
$4.49 |
$4.54 |
4.02M |
|
Fate Therapeutics is a clinical-stage biopharmaceutical company focused on the development of programmed cellular immunotherapies for patients with cancer. Co. is developing cell therapy product candidate. Co.'s off-the-shelf, induced pluripotent stem cells (iPSC) derived cellular immunotherapy pipeline include: FT516, which is an off-the-shelf natural killer (NK) cell cancer immunotherapy derived from a clonal master iPSC line engineered to express a high-affinity, non-cleavable CD16 Fc receptor; and FT596, which is an off-the-shelf chimeric antigen receptor NK cell cancer immunotherapy derived from a clonal engineered master iPSC line. | |
|
Fate Therapeutics (FATE) has the following price history information. Looking back at FATE historical stock prices for the last five trading days, on April 17, 2024, FATE opened at $5.50, traded as high as $5.63 and as low as $5.21, and closed at $5.27. Trading volume was a total of 2.15M shares. On April 18, 2024, FATE opened at $5.27, traded as high as $5.35 and as low as $4.98, and closed at $5.04. Trading volume was a total of 2.34M shares. On April 19, 2024, FATE opened at $4.95, traded as high as $5.11 and as low as $4.70, and closed at $4.79. Trading volume was a total of 2.69M shares. On April 22, 2024, FATE opened at $4.84, traded as high as $4.92 and as low as $4.67, and closed at $4.78. Trading volume was a total of 1.43M shares. On April 23, 2024, FATE opened at $4.79, traded as high as $5.02 and as low as $4.49, and closed at $4.54. Trading volume was a total of 4.02M shares.
FATE Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Fate Therapeutics shares, starting with a $10,000 purchase of FATE, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/25/2014 |
|
End date: |
04/23/2024 |
|
Start price/share: |
$6.97 |
|
End price/share: |
$4.54 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-34.86% |
|
Average Annual Total Return: |
-4.20% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$6,510.35 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/17/2024 | $5.27 | 04/18/2024 | $5.04 | 04/19/2024 | $4.79 | 04/22/2024 | $4.78 | 04/23/2024 | $4.54 |
|
|